| Tara L Lawless, APRN | |
|
1201 N Erie St, Lexington, NE 68850-1571 | |
| (308) 324-5651 | |
| (308) 324-8359 |
| Full Name | Tara L Lawless |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1201 N Erie St, Lexington, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649685611 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 120084 (Nebraska) | Secondary |
| 363L00000X | Nurse Practitioner | 111659 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lexington Regional Health Center | Lexington, NE | Hospital |
| Kearney Regional Medical Center | Kearney, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lexington Regional Health Center | 2860415874 | 25 |
News Archive
A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014.
Today the National Institute for Health and Care Excellence has approved the use of MabThera for two potentially life-threatening auto-immune diseases, GPA and MPA, which result in the inflammation and damage of small blood vessels and frequently involve multiple organs. The two diseases affect over 13,000 people in the UK and are characterised by the breaking down of specific areas of tissue in the body that, if not treated, can lead to organ damage, organ failure and even death.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a 4 week Phase 1 trial of its new self-applied ViaDerm-hPTH(1-34) for the treatment of osteoporosis.
Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.
Scientists at the University of Liverpool have discovered that dangerous strains of Salmonella are beginning to emerge in people infected with HIV in Africa.
› Verified 5 days ago
| Entity Name | Lexington Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316016165 PECOS PAC ID: 2860415874 Enrollment ID: O20060105000221 |
News Archive
A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014.
Today the National Institute for Health and Care Excellence has approved the use of MabThera for two potentially life-threatening auto-immune diseases, GPA and MPA, which result in the inflammation and damage of small blood vessels and frequently involve multiple organs. The two diseases affect over 13,000 people in the UK and are characterised by the breaking down of specific areas of tissue in the body that, if not treated, can lead to organ damage, organ failure and even death.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a 4 week Phase 1 trial of its new self-applied ViaDerm-hPTH(1-34) for the treatment of osteoporosis.
Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.
Scientists at the University of Liverpool have discovered that dangerous strains of Salmonella are beginning to emerge in people infected with HIV in Africa.
› Verified 5 days ago
| Entity Name | Lexington Regional Health Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1467417352 PECOS PAC ID: 2860415874 Enrollment ID: O20071129000331 |
News Archive
A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014.
Today the National Institute for Health and Care Excellence has approved the use of MabThera for two potentially life-threatening auto-immune diseases, GPA and MPA, which result in the inflammation and damage of small blood vessels and frequently involve multiple organs. The two diseases affect over 13,000 people in the UK and are characterised by the breaking down of specific areas of tissue in the body that, if not treated, can lead to organ damage, organ failure and even death.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a 4 week Phase 1 trial of its new self-applied ViaDerm-hPTH(1-34) for the treatment of osteoporosis.
Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.
Scientists at the University of Liverpool have discovered that dangerous strains of Salmonella are beginning to emerge in people infected with HIV in Africa.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tara L Lawless, APRN Po Box 980, Lexington, NE 68850-0980 Ph: (308) 324-5651 | Tara L Lawless, APRN 1201 N Erie St, Lexington, NE 68850-1571 Ph: (308) 324-5651 |
News Archive
A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014.
Today the National Institute for Health and Care Excellence has approved the use of MabThera for two potentially life-threatening auto-immune diseases, GPA and MPA, which result in the inflammation and damage of small blood vessels and frequently involve multiple organs. The two diseases affect over 13,000 people in the UK and are characterised by the breaking down of specific areas of tissue in the body that, if not treated, can lead to organ damage, organ failure and even death.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a 4 week Phase 1 trial of its new self-applied ViaDerm-hPTH(1-34) for the treatment of osteoporosis.
Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.
Scientists at the University of Liverpool have discovered that dangerous strains of Salmonella are beginning to emerge in people infected with HIV in Africa.
› Verified 5 days ago
Stephanie L Reutlinger, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 Fax: 308-324-8359 | |
Travis L Barkmeier, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 Fax: 308-324-8359 | |
Kaitlyn M Lemmer, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 Fax: 308-324-8359 | |
Raime L Misko, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 Fax: 308-324-8359 | |
Barbara J Foss, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 Fax: 308-324-8359 | |
Julie Christine Thies, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 Fax: 308-324-8359 | |
Nicole C Thorell, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-5651 Fax: 308-324-8359 |